Molecular basis for the resistance of fibrin-bound thrombin to inactivation by heparin/serpin complexes

Advances in Experimental Medicine and Biology

Volumn 425, Issue , 1997, Pages 55-66

  Becker, Debra L ^a   Fredenburgh, Jim C ^a   Stafford, Alan R ^a   Weitz, Jeffrey I ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 10A INHIBITOR; FIBRIN; HEPARIN; HEPARIN COFACTOR II; HIRUDIN; PROCOAGULANT; SERINE PROTEINASE INHIBITOR; THROMBIN; THROMBIN INHIBITOR;

ALLOSTERISM; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; ENZYME ACTIVE SITE; ENZYME INHIBITOR COMPLEX; ENZYME MECHANISM; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEINASE INHIBITION; STEREOSPECIFICITY; THROMBOCYTE ACTIVATION;

ANIMALS; ANTICOAGULANTS; BINDING SITES; CORONARY DISEASE; FIBRIN; HEPARIN; HIRUDIN THERAPY; HUMANS; SERPINS; THROMBIN; THROMBOSIS;

EID: 0031439715     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5391-5_6     Document Type: Article

References (32)

1. Arni, R.K., Padmanabhan, K., Padmanabhan, K.P., Wu, T.P., and Tulinsky, A. (1993) Structures of the non-covalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. Biochemistry 32: 4727-4737.
2. Banninger, H., Lammle, B., and Furlan, M. (1994) Binding of α-thrombin to fibrin depends on the quality of the fibrin network. Biochem. J. 298: 157-163.
3. Berliner, L.J., Sugawara, Y., and Fenton, J.W.H. (1985) Human α-thrombin binding to non-polymerized fibrin-Sepharose: evidence for an anionic binding region. Biochemistry 24: 7005-7009.
4. Binnie, C., and Lord, S.T. (1993) The fibrinogen sequences that interact with thrombin. Blood 81: 3186-3192.
5. Bittl, J.A., Strony, J., Brinker, J.A., Ahmed, W.H., Meckel, C.R., Chaitman, B.R., Maraganore, J., Deutsch, E., and Adelman, B. (1995) Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N. Engl. J. Med. 333: 764-769.
6. Bode, W., Turk, D., and Karshikov, A. (1992) The refined 1.9-Å x-ray crystal structure of D-Phe-Pro-Arg-chloromethyl ketone-inhibited human α-thrombin: structure analysis, overall structure, electrostatic properties, detailed active site geometry, and structure-function relationships. Protein Sci. l: 426-471.
7. Collins, R., MacMahon, S., Flather, M., Baigent, C., Remvig, L., Mortensen, S., Appleby, P., Godwin, J., Yusuf, S., and Peto, R. (1996) Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomized trial. BMJ 313: 652-659.
8. Cruickshank, M.K., Levine, M.N., Hirsh, J., Roberts, R., and Siguenza, M. (1991) A standard heparin nomogram for the management of heparin therapy. Arch. Intern. Med. 151:333-337.
9. Eisenberg, P.R., Sherman, L.A., and Jaffe, A.S. (1987) Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysis. J. Am. Coll. Cardiol. 10: 527-529.
10. Eisenberg, P.R., Siegel, J.E., Abendschein, D.R., and Miletich, J.P. (1993) Importance of factor Xa in determining the procoagulant activity of whole blood clots. J. Clin. Invest. 91: 1877-1883.
11. Esmon, C.T., and Lollar, P.T. (1996) Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII. J. Biol. Chem. 271: 13882-13887.
12. Fenton, J.W. II, Olson, T.A., Zabinski, M.P., and Wilner, G.D. (1988) Anion-binding exosite of human alphathrombin and fibrin(ogen) recognition. Biochemistry 27: 7106-7112.
13. Galvani, M., Abendschein, D.R., Ferrini, D., Ottani, F., Rusticali, F., and Eisenberg, P.R. (1994) Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase. J. Am. Coll. Cardiol. 24: 1445-1452.
14. Granger, C.B., Hirsh, J., Califf, R.M., Woodlief, L.H., Bovill, E., Simes, R.J., and Topol, E.J. (1996) Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO Trial. Circulation 93: 870-888.
15. Granger, C.B., Miller, J.M., Bovill, E.G., Gruber, A., Tracy, R.P., Krucoff, M.W., Green, C., Berrios, E., Harrington, R.A., Ohman, E.M., et al. ( 1995) Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 91: 1929-1935.
16. GUSTO Investigators (1996) A comparison of recombinant hirudin with heparin for treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) llb Investigators. N. Engl. J. Med. 335: 775-782.
17. Henriksen, R.A., Owen, W.G., Nesheim, M.E., and Mann, K.G. (1980) Identification of a congenital dysthrombin, thrombin Quick. J. Clin. Invest. 66: 934-940.
18. Hogg, P.J., and Jackson, C.M. (1989) Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy. Proc. Natl. Acad. Sci. USA 86: 3619-3623.
19. Hogg, P.J., and Jackson, C.M. (1990a) Heparin promotes the binding of thrombin to fibrin polymer: quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex. J. Biol. Chem. 265: 241-247.
20. Hogg, P.J., and Jackson, C.M. (1990b) Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates. J. Biol. Chem. 265: 248-255.
21. Hogg, P.J., Jackson, C.M., Labanowski, J.K., and Bock, P.E. (1996) Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen. J. Biol. Chem. 271: 26088-26095.
22. Kaminski, M., and McDonagh, J. (1983) Studies of the mechanism of thrombin interaction with fibrin. J. Biol. Chem. 258: 10530-10535.
23. Kaminski, M., and McDonagh, J. (1987) Inhibited thrombins: interactions with fibrinogen and fibrin. Biochem. J. 242: 881-887.
24. Kumar, R., Beguin, S., and Hemker, C. ( 1994) The influence of fibrinogen and fibrin on thrombin generation -Evidence for feedback activation of the clotting system by clot bound thrombin. Thromb. Haemost. 72: 713-721.
25. Kumar, R., Beguin, S., and Hemker, C. (1995) The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity. Thromb. Haemost. 74(3): 962-968.
26. Liu, C.Y., Nossel, H.L., and Kaplan, K.L. (1979) The binding of thrombin by fibrin. J. Biol. Chem. 254: 10421-10425.
27. Maraganore, J.M., Bourdon, P., Jablonski, J., Ramachandran, K.L., and Fenton, J.W.H. (1990) Design and characterization of Hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry 29: 7095-7101.
28. Maraganore, J.M., Chao, B., Joseph, M.L., Jablonski, J., and Ramachandran, K.L. ( 1989) Anticoagulant activity of synthetic hirudin peptides. J. Biol. Chem. 264: 8692-8698.
29. Meh, D.A., Siebenlist, K.R., and Mosesson, M.W. (1996) Identification and characterization of the thrombin binding sites on fibrin. J. Biol. Chem. 271: 23121-23125.
30. Merlini, P.A., Bauer, K.A., Oltrona, L., Ardissino, D., Spinola, A., Cattaneo, M., Broccolino, M., Mannucci, P.M., and Rosenberg, R.D. (1995) Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 25: 203-209.
31. Mohri, H., Iwamatsu, A., and Ohkubo, T. (1994) Heparin binding sites are located in a 40-kD γ-chain and a 36-kD β-chain fragment isolated from human fibrinogen. J. Thromb. Thrombolysis 1: 49-54.
32. Mosesson, M.W., and Finlayson, J.S. (1963) Subfractions of human fibrinogen. Preparation and analysis. J. Lab. Clin. Med. 62: 663-674.